 |
Amylin
and Lilly partner to develop new pen device for diabetes therapy |
| |
Amylin Pharmaceuticals, a biopharmaceutical
company, and Eli Lilly and Company have agreed in principle to
cooperate in the development, manufacturing and marketing of exenatide
once weekly in a dual chamber cartridge pen configuration (Trading
Markets) |
| |
|
|
Insulin
blunts the response of glucose-excited neurons in the ventrolateral-ventromedial
hypothalamic nucleus to decreased glucose |
| |
These data are consistent with the role of insulin
as a satiety factor (AJPl Endocrinology and Metabolism) |
| |
|
|
Independent
anti-inflammatory effect of insulin in newly diagnosed type 2
diabetes |
| |
Our data suggest that insulin has an anti-inflammatory
effect that is independent of the reduction it causes in blood
glucose (Diabetes/Metabolism Research and Reviews) |
| |
|
|
Putting
Feet First |
| |
You are invited to the launch of the new Foot
Care Guidance for the commissioning of diabetes hospital foot care
services (NHS Diabetes) |
| |
|
|
Visit us on Twitter also RSS
feed of Glycosmedia via Twitter |
| |
|
| |
|
